LWA
Lowe Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4
| Closed | -$225 | – | 316 |
|
|
2023
Q2 | $225 | Hold |
4
| – | – | ﹤0.01% | 346 |
|
|
2023
Q1 | $181 | Hold |
4
| – | – | ﹤0.01% | 341 |
|
|
2022
Q4 | $163 | Hold |
4
| – | – | ﹤0.01% | 349 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 338 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 317 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 319 |
|
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 297 |
|
|
2021
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 282 |
|
|
2021
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 260 |
|
|
2021
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 275 |
|
|
2020
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 247 |
|
|
2020
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 260 |
|
|
2020
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 271 |
|
|
2020
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 312 |
|